TY  - JOUR

T1  - Comparison of cisplatin/gemcitabine or carboplatin/gemcitabine on efficacy, toxicity, and quality of life from the randomized DISCUS trial.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2026.44.16_suppl.4583

PY  - 2026/05/27

AU  - Hussain SA

AU  - García Carbonero I

AU  - Molina Cerrillo J

AU  - Puente J

AU  - Borrega P

AU  - Malik J

AU  - Dourthe L-M

AU  - Jones R

AU  - Castellano D

AU  - Loriot Y

AU  - Jackson-Spence F et al

ED  - 

DO  - DOI: 10.1200/jco.2026.44.16_suppl.4583

PB  - American Society of Clinical Oncology (ASCO)

VL  - 44

IS  - 16_suppl

SP  - 4583

EP  - 4583

Y2  - 2026/06/21

ER  -